Protein | Gene Symbol | All allelic disease phenotypes - locus/disease symbols |
| Bag cochaperone | |  * Dilated cardiomyopathy, 2F - CMD2F (10.87)
|
BCL2-associated athanogene 3 | | * myofibrillar myopathy with bag3 defect - (5.7, 10.72, 14.82)
* Charcot-Marie-Tooth disease, axonal, related to BAG3 - (5.7, 10.72, 14.82)
* Dilated cardiomyopathy related to BAG3 - CMD1HH (5.7, 10.72, 14.82)
| BET1 golgi vesicular membrane-trafficking protein | | * Congenital muscular dystrophy with epilepsy - (2.53)
| Beta sarcoglycan | | * Muscular dystrophy, limb-girdle, type 2E - LGMD2E (1.28)
| Beta-1,3-N-acetylgalacto-saminyltransferase 2 | | * Congenital muscular dystrophy with hypoglycosylation of dystroglycan WWWS/MEB li - MDDGA11 (2.28)
| Beta-1,4-N-acetyl-galactosaminyl transferase 1 | | * Charcot-Marie-Tooth disease, axonal - (14.103, 15.39)
* Spastic paraplegia 26 - SPG26 (14.103, 15.39)
| Bicaudal D homolog 2 (Drosophila) | | * Arthrogryposis and BICD2-related neuromuscular disease - (12.41, 12.42, 16.24)
* Spinal muscular atrophy, lower extremity, autosomal dominant 2 - SMALED2A (12.41, 12.42, 16.24)
* Spinal muscular atrophy, lower extremity-predominant, autosomal dominant 2B - SMALED2B (12.41, 12.42, 16.24)
| Blood vessel epicardial substance | | * Limb-Girdle, Muscular dystrophy, type 2X - LGMD2X (1.42)
| Brain expressed, associated with Nedd42 | | * spinocerebellar ataxia-31 - SCA31 (13.29)
|
